Результати пошуку

з
 
  


п/п
Номер
патенту
Назва винаходу та фрагмент реферату Дата публікації патента
1 SG173024A1
SYSTEM AND METHOD FOR ANALYZING A BODY FLUID

AbstractThe invention concerns a system for analyzing a body fluid comprising a collecting element (14) which receives the body fluid (32) in a reservoir (28), a test element (18) designed to detect an analyte in the body fluid (32), a transfer device (20) formaking a fluidic connection between the collecting element (14) and the test element (18), and a detection unit (22) which detects an analyt...

29.08.2011
2 SG173025A1
ELECTROCHEMICAL DEVICE AND PROCESS OF MANUFACTURING SAME

ELECTROCHEMICAL DEVICE AND PROCESS OF MANUFACTURING SAMEAn electrochemical device capable of enhancing sealing performance of a lead terminal leading portion in an exterior film for accommodating an electrochemical element is provided. In an electrochemical device in which an electrochemical element 10 is covered by a laminated outer packaging film 4 having at least an inneimost layer 41 made of h...

29.08.2011
3 SG173026A1
SIGNAL ENCODING METHOD AND APPARATUS, UNITED FEEDBACK SIGNAL ENCODING METHOD

A signal encoding method and device and a method for encoding a joint feedback signal are provided. The signal encoding method includes the following steps. When two carriers are configured with multiple-input and multiple-output (MIMO), Hybrid Automatic Repeat reQuest-ACKnowledgement (HARQ-ACK) signals of the two carriers are combined into a joint feedback signal. The joint feedback signal is map...

29.08.2011
4 SG173027A1
N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF

N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF 3 xel ,3FN.,XA a[1]An N-acyl anthranilic acid derivative represented by general formula (1) or a salt thereof is useful for prevention or treatment of diseases associated with excessive production of collagen. (In the formula, Rl represents a carboxyl group or the like; R2 represents a hydrogen atom or the like; R3 represents an optionally substit...

29.08.2011
5 SG173028A1
IMIDAZOTHIAZOLE DERIVATIVE HAVING PROLINE RING STRUCTURE

- 183 -[Document Name] Abstract[Abstract][Problem to be Solved]There is provided a novel compound that inhibits interaction between mUrine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity. [Solution]The present invention provides an imidazothiazole derivative represented by the following formula (1)having various substituents that inhibits interaction between Mdm2 pr...

29.08.2011
6 SG173029A1
CARRYING CASE

A system for maintaining a large number of Handheld Electronic Devices is implemented as a carrying case having circuitry configured to connect to the Handheld Electronic Devices to enable the HEDs to be charged and synchronized. The carrying case has a central area configured to hold the circuitry for charging and synchronizing the HEDs, and a pair of divider structures on either side of the cent...

29.08.2011
7 SG173030A1
A SYSTEM, METHOD AND APPARATUS FOR IMPLEMENTING DENTAL IMPLANTS

A system, apparatus, device, tools and method is provided for the insertion of improved anatomically corrected modular design anterior and posterior dental implants, the apparatus including a root component and a head/abutment component, wherein the root component is inserted into the jawbone using precision surgical guide tools in combination with self-limiting surgical templates and a precision ...

29.08.2011
8 SG173031A1
COVERED CABLE ASSEMBLIES AND METHODS AND SYSTEMS FOR FORMING THE SAME

A covered cable assembly includes a cable and a sealing assembly. The cable includes a metal sheath and a cable core. The metal sheath has a sheath terminal edge defining a sheath opening. The cable core extends through the metal sheath. The cable core includes an electrical conductor and an oil-impregnated paper insulation layer surrounding the electrical conductor. An extended cable core section...

29.08.2011
9 SG173032A1
PHARMACEUTICAL COMPOSITION COMPRISING GLUCOPYRANOSYL DIPHENYLMETHANE DERIVATIVES, PHARMACEUTICAL DOSAGE FORM THEREOF, PROCESS FOR THEIR PREPARATION AND USES THEREOF FOR IMPROVED GLYCEMIC CONTROL IN A PATIENT

The present invention relates to pharmaceutical compositions comprising a SGLT-2 inhibitor, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders.

29.08.2011
10 SG173033A1
METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER

The present invention relates to the identification of nucleic acid and amino acid sequences that are characteristic of colorectal, in particular colonic, and gastric tumor tissues and colorectal, in particular colonic, and gastric tissues, and which represent targets for therapy or diagnosis of such tumor diseases in a subject.

29.08.2011
11 SG173034A1
METHOD, APPARATUS, AND COMPUTER PROGRAM PRODUCT FOR CONTEXT-BASED CONTACT INFORMATION MANAGEMENT

An apparatus for context-based contact information management may include a processor. The at least one processor may be configured to receive contact information and associated sender-based context information. In this regard, the contact information and sender-based context information may have been transmitted from a sending device. The at least one processor may also be configured to associate...

29.08.2011
12 SG173035A1
SPLIT VALVE

A split valve apparatus for the control, charging, discharging and/or regulating the flow of powders, liquids, slurries and/or fluids. The valve has two valve portions complementarily shaped such that the first can sealingly engage with and co-operate with the second to allow the flow of material therethrough. Each valve portion comprises a housing, a valve seat and a valve closure member, which i...

29.08.2011
13 SG173036A1
PHARMACEUTICAL COMPOSITION COMPRISING LINAGLIPTIN AND OPTIONALLY A SGLT2 INHIBITOR, AND USES THEREOF

The present invention relates to pharmaceutical compositions of linagliptin, pharmaceutical dosage forms, their preparation, their use and methods for treating metabolic disorders.

29.08.2011
14 SG173037A1
METHOD FOR PRODUCING TOOTH

Disclosed is a method for producing a tooth having a desired length in one direction. Specifically disclosed is a method for producing a tooth having a desired length in one direction, which comprises the steps of: placing a first cell aggregate and a second cell aggregate in the inside of a support while bringing the first and second cell aggregates into close contact with each other; and culturi...

29.08.2011
15 SG173038A1
HIGH-PERFORMING ELECTROPHORESIS GELS WITH EXTENDED SHELF LIVES

Polyacrylamide gels that offer high resolution as electrophoretic media for protein separations and an improved resistance to hydrolysis upon storage are made by including either taurine, asparagine, or both as an ampholyte, in combination with either tris(hydroxymethyl)aminomethane or bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane as a buffer, plus other conventional components.

29.08.2011
16 SG173039A1
STOCHASTIC INVERSION OF GEOPHYSICAL DATA FOR ESTIMATING EARTH MODEL PARAMETERS

A computer implemented stochastic inversion method for estimating model parameters of an earth model. In an embodiment, the method utilizes a sampling-based stochastic technique to determine the probability density functions (PDF) of the model parameters that define a boundary-based multi-dimensional model of the subsurface. In some embodiments a sampling technique known as Markov Chain Monte Carl...

29.08.2011
17 SG173040A1
METHOD FOR INTRODUCING CARBON PARTICLES INTO A POLYURETHANE SURFACE LAYER

Abstract Process Process for incorporating carbon particles into a polyurethane surface layerThe invention relates to a method for introducing electrically conductive carbon particles into a surface layer comprising polyurethane. These carbon particles can in particular be carbon nanotubes. In the methodaccording to the invention, a solution of non-aggregated carbon particles having a mean particl...

29.08.2011
18 SG172320A1
NOVEL MICROBIOCIDES

Compounds of formula (I), in which the substituents are as defined in claim 1, are suitable for use as microbiocides.

29.08.2011
19 SG172360A1
COMPOSITION FOR POST CHEMICAL-MECHANICAL POLISHING CLEANING

The present invention relates to a composition for post chemical-mechanical polishing (CMP) cleaning. The composition is alkaline, which can remove azole-type corrosion inhibitors on the wafer surface after CMP. This composition can effectively remove azole compounds, increase wettability of the Cu surface, and significantly improve the defect removal after CMP.

29.08.2011
20 SG172385A1
DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS

Compounds of the formula (I) or pharmaceutically acceptable salts thereof, wherein m, n, p, q, R1, R2, R3, R4, R5 and R6 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with the P2X7 purinergic receptor.

29.08.2011